Vol 95, No 10 (2024)
Other materials agreed with the Editors
Published online: 2024-10-31

open access

Page views 212
Article views/downloads 134
Get Citation

Connect on Social Media

Connect on Social Media

Fetal therapy guidelines — fetal echocardiography is of special value. Statement of the Polish Prenatal Cardiology Society

Maria Respondek-Liberska12, Oskar Sylwestrzak13, Maciej Slodki14, Iwona Strzelecka12
Pubmed: 39513225
Ginekol Pol 2024;95(10):759-762.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Kosinski P, Borowski D, Brawura-Biskupski-Samaha R, et al. Fetal therapy guidelines of the Polish Society of Gynecologists and Obstetricians — Fetal Therapy Section. Ginekol Pol. 2024; 95(4): 285–315.
  2. Słodki M, Respondek-Liberska M. Fetal echocardiography: one of the most important tools in fetal diagnosis and assessing wellbeing. J Clin Ultrasound. 2022; 50(5): 636–638.
  3. Sylwestrzak O, Strzelecka I, Słodki M, et al. Fetal echocardiography is not only used to detect congenital heart disease but also to monitor fetuses, especially those with different pathologies. Kardiol Pol. 2022; 80(9): 966–967.
  4. Nowakowska A, Sylwestrzak O, Strzelecka I, et al. Prenatal echocardiography in Trisomy 18 — the key to diagnosis and further management in the second half of pregnancy. Ginekol Pol. 2023; 94(5): 366–373.
  5. Kornacki J, Adamczyk M, Wirstlein P, et al. Polyhydramnios — frequency of congenital anomalies in relation to the value of the amniotic fluid index. Ginekol Pol. 2017; 88(8): 442–445.
  6. Graupner O, Enzensberger C, Götte M, et al. Myocardial function in fetuses with lower urinary tract obstruction: Is there a cardiac remodeling effect due to renal damage? Prenat Diagn. 2019; 39(7): 495–504.
  7. Pasieczna M, Kuran-Ohde J, Grzyb A, et al. Value of fetal echocardiographic examination in pregnancies complicated by preterm premature rupture of membranes. J Perinat Med. 2024; 52(5): 538–545.
  8. Oluklu D, Menekse Beser D, Uyan Hendem D, et al. Assessment of fetal cardiac morphology and functional changes in early-onset and late-onset fetal growth restriction. Int J Gynaecol Obstet. 2023; 161(1): 241–249.
  9. Sileo FG, Kulkarni A, Branescu I, et al. Non-immune fetal hydrops: etiology and outcome according to gestational age at diagnosis. Ultrasound Obstet Gynecol. 2020; 56(3): 416–421.
  10. Ojala TH, Hornberger LK. Fetal heart failure. Front Biosci (Schol Ed). 2010; 2(3): 891–906.
  11. Gottschalk I, Gottschalk L, Stressig R, et al. Ebstein's anomaly of the tricuspid valve in the fetus — a multicenter experience. Ultraschall Med. 2017; 38(4): 427–436.
  12. Kaczmarek P, Jaczewski B, Oszukowski P, et al. [Non-immune hydrops fetalis--prognostic factors based on fetal echo (analysis in 230 cases)]. Ginekol Pol. 2003; 74(10): 1112–1117.
  13. Bigras JL, Suda K, Dahdah NS, et al. Cardiovascular evaluation of fetal anemia due to alloimmunization. Fetal Diagn Ther. 2008; 24(3): 197–202.
  14. Michel M, Schmitz R, Kiesel L, et al. Fetal myocardial peak systolic strain before and after intrauterine red blood cell transfusion — a tissue Doppler imagingstudy. J Perinat Med. 2012; 40(5): 545–550.
  15. Luewan S, Tongprasert F, Srisupundit K, et al. The accelerated right ventricular failure in fetal anemia in the presence of restrictive foramen ovale. Diagnostics (Basel). 2022; 12(7).
  16. Reyna-Villasmil E, Briceño-Sanabria L, Briceño-Sanabria JC, et al. Prenatal ultrasound diagnosis of unilateral pulmonary agenesis. J Med Ultrasound. 2024; 32(3): 259–261.
  17. Sliwka A, Sztyler-Krakowska M, Bielasik K, et al. Prenatal diagnosis of scimitar syndrome. Ginekol Pol. 2024 [Epub ahead of print].
  18. Sokołowski Ł, Pałgan M, Strzelecka I, et al. Prenatal diagnosis of right-sided congenital diaphragmatic hernia. Prenat Cardiol. 2023; 2023(1).
  19. Kosiv KA, Moon-Grady A, Hogan W, et al. Fetal cerebrovascular impedance is reduced in left congenital diaphragmatic hernia. Ultrasound Obstet Gynecol. 2021; 57(3): 386–391.
  20. Moon-Grady AJ, Byrne FA, Lusk LA, et al. Expected small left heart size in the presence of congenital diaphragmatic hernia: fetal values and Z-scores for infants confirmed to have no heart disease postnatally. Front Pediatr. 2022; 10: 1083370.
  21. Krekora M, Sokołowski Ł, Murlewska J, et al. Small prenatal diameter of the ascending aorta is associated with increased mortality risk in neonates with congenital diaphragmatic hernia. Arch Med Sci. 2023; 19(4): 1022–1027.
  22. Murlewska J, Sylwestrzak O, Respondek-Liberska M. Unfavorable postnatal outcome with significant dilation of the fetal main pulmonary artery near term. Birth Defects Res. 2021; 113(1): 55–62.
  23. Sylwestrzak O, Murlewska J, Sokołowski Ł, et al. Increased maternal phenylalanine concentration may influence not only fetal heart structural development but also cardiovascular function and pulmonary tissue development in humans — a case report. Prenat Cardiol. 2023; 2023(1).
  24. Nowakowska A, Krekora M, Talar T, et al. Prenatal diagnosis of hypoplastic left heart syndrome with PAPVC and FO restriction and pulmonary hypertension – coexisting factors suggesting poor prognosis due to pulmonary hypertension with histopathological confirmation. Prenat Cardiol. 2022; 1: 25–30.
  25. Degenhardt J, Enzensberger C, Tenzer A, et al. Myocardial function pre- and post-fetal endoscopic tracheal occlusion (FETO) in fetuses with left-sided moderate to severe congenital diaphragmatic hernia. Ultraschall Med. 2017; 38(1): 65–70.
  26. See AP, Wilkins-Haug LE, Benson CB, et al. Percutaneous transuterine fetal cerebral embolisation to treat vein of Galen malformations at risk of urgent neonatal decompensation: study protocol for a clinical trial of safety and feasibility. BMJ Open. 2022; 12(5): e058147.
  27. Mendez A, Codsi E, Gonzalez Barlatay F, et al. Pulmonary hypertension associated with vein of Galen malformation. Fetal cardiac hemodynamic findings and physiological considerations. J Perinatol. 2022; 42(1): 143–148.
  28. Jhaveri S, Berenstein A, Srivastava S, et al. High output cardiovascular physiology and outcomes in fetal diagnosis of vein of galen malformation. Pediatr Cardiol. 2021; 42(6): 1416–1424.
  29. Turkyilmaz G, Arisoy R, Turkyilmaz S, et al. The outcome of the vein of Galen aneurysmal malformation cases diagnosed prenatally. J Obstet Gynaecol. 2022; 42(5): 1137–1141.
  30. Respondek-Liberska M, Słodki M. Prognosis for newborns with vein of Galen malformation diagnosed prenatally based on a new scale. Prenat Cardiol. 2019; 2019(1): 37–41.
  31. Grzesiak M, Respondek-Liberska M, Szaflik K, et al. [Fetal posteriorurethralvalve (PUV) in database of Department of the Diagnosis and Prophylaxis of Congenital Malformation Institute Polish “Mother's Memorial Hospital” in 1994–2002 and echocardiographic results]. Ginekol Pol. 2003; 74(10): 1088–1092.
  32. Graupner O, Enzensberger C, Götte M, et al. Myocardial function in fetuses with lower urinary tract obstruction: Is there a cardiac remodeling effect due to renal damage? Prenat Diagn. 2019; 39(7): 495–504.
  33. Rychik J, McCann M, Tian Z, et al. Fetal cardiovascular effects of lower urinary tract obstruction with giant bladder. Ultrasound Obstet Gynecol. 2010; 36(6): 682–686.
  34. Cohen J, Levasseur S, Simpson L, et al. Fetal cardiac findings and hemodynamic changes associated with severe lower urinary tract obstruction in utero. Ultrasound Obstet Gynecol. 2019; 54(6): 780–785.
  35. Słodki M, Janiak K, Szaflik K, et al. [Fetal echocardiography in fetal ovarian cysts]. Ginekol Pol. 2008; 79(5): 347–351.
  36. Słodki M, Janiak K, Szaflik K, et al. Fetal echocardiography before and after prenatal aspiration of a fetal ovarian cyst. Ginekol Pol. 2009; 80(8): 629–631.
  37. Van Mieghem T, Lewi L, Gucciardo L, et al. The fetal heart in twin-to-twin transfusion syndrome. Int J Pediatr. 2010; 2010.
  38. Rychik J, Tian Z, Bebbington M, et al. The twin-twin transfusion syndrome: spectrum of cardiovascular abnormality and development of a cardiovascular score to assess severity of disease. Am J Obstet Gynecol. 2007; 197(4): 392.e1–392.e8.
  39. Zanardini C, Prefumo F, Fichera A, et al. Fetal cardiac parameters for prediction of twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol. 2014; 44(4): 434–440.
  40. Leszczyńska K, Preis K, Respondek-Liberska M, et al. Recommendations for fetal echocardiography in twin pregnancy in 2016. Prenat Cardiol. 2016; 6(1): 6–15.
  41. Respondek-Liberska M. Diagnostyka prenatalna USG/ECHO. Wady wymagające interwencji chirurgicznej. PZWL, Warszawa 2016.
  42. Respondek-Liberska M. Diagnostyka prenatalna USG/ECHO. Zmiany czynnościowe w układzie krążenia płodu. PZWL, Warszawa 2019.
  43. Respondek-Liberska M. Wady serca płodu. Diagnostyka i postępowanie. PZWL, Warszawa 2022.
  44. Słodki M. Opracowanie modelu opieki nad ciężarną z wrodzoną wadą serca u płodu na podstawie nowego prenatalnego podziału wad serca. Rozprawa habilitacyjna. Wydawnictwo PWSZ W PŁOCKU, Łódź 2012.
  45. Słodki M, Copel JA, Rizzo G, et al. Endorsed by The International Prenatal Cardiology Collaboration Group. Fetal cardiology: is it time to establish a separate independent medicine subspeciality? Pediatr Cardiol. 2022; 43(7): 1676–1677.